Welcome to LookChem.com Sign In|Join Free
  • or
N-[2-(4-HYDROXYPHENYLSULFANYL)ETHYL]PROPIONAMIDE is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

155196-03-5

Post Buying Request

155196-03-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

155196-03-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 155196-03-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,5,1,9 and 6 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 155196-03:
(8*1)+(7*5)+(6*5)+(5*1)+(4*9)+(3*6)+(2*0)+(1*3)=135
135 % 10 = 5
So 155196-03-5 is a valid CAS Registry Number.

155196-03-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name N-[2-(4-hydroxyphenyl)sulfanylethyl]propanamide

1.2 Other means of identification

Product number -
Other names N-propionyl-4-S-cysteaminylphenol

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:155196-03-5 SDS

155196-03-5Downstream Products

155196-03-5Relevant academic research and scientific papers

A simple and efficient synthesis of N-[2-{(4-propionyloxyphenyl)thio}ethyl] propionamide (DIPCAP), a tyrosine-dependent cytotoxic agent as a topical antimelanoma therapy

Coutts, Lisa D.,Meckler, Harold,Popp, Karl F.

, p. 2697 - 2704 (2004)

The synthesis of N-[2-{(4-propionyloxyphenyl)thio}ethyl]propionamide (DIPCAP), a tyrosine-dependent cytotoxic agent that is currently being evaluated as a topical antimelanoma treatment is described. Problems encountered in scaling up the original patent

Synthesis and antitumour effect of the melanogenesis-based antimelanoma agent N-Propionyl-4-S-cysteaminylphenol

Tandon, Manju,Thomas, Panakkezhum D.,Shokravi, Mohammed,Singh, Shradha,Samra, Satinder,Chang, Daniel,Jimbow, Kowichi

, p. 2023 - 2029 (1998)

Chemotherapy of malignant melanoma is still a great challenge, as no effective drugs are available. The development of melanogenesis-based drugs is a promising area of research because melanogenesis is a unique biochemical pathway operating only in melano

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 155196-03-5